In trading on Monday, shares of Macy's Inc (Symbol: M) crossed below their 200 day moving average of $18.86, changing hands as low as $18.71 per share. Macy's Inc shares are currently trading off about 3.8% on the day. The chart below shows the one year performance of M shares

格隆汇5月12日｜道琼斯指数5月11日（周一）收盘上涨95.31点，涨幅0.19%，报49704.47点； 标普500指数5月11日（周一）收盘上涨13.90点，涨幅0.19%，报7412.83点； 纳斯达克综合指数5月11日（周一）收盘上涨27.05点，涨幅0.10%，报26274.13点。

Conduent press release ( CNDT ): Q1 Non-GAAP EPS of -$0.07 beats by $0.12 . Revenue of $723M (-3.7% Y/Y) misses by $23.5M . Pre-tax Income (Loss): $(27)M, improved by $29M year-over-year Adj. EBITDA: $49M, improved by $12M year-over-year Adj. EBITDA Margin: 6.8%, improved by 190 bps year-over-year Cash flow from operating activities: $(8)M, improved by $50M year-over-year. FY 2026 and 2027 Outlook (3) FY 2026Outlook (3) FY 2027Outlook (3) Revenue $2,800M - $2,900M Flat to positive Adj. EBITDA (1) $160M - $190M $190M - $220M Click to enlarge More on Conduent Conduent Incorporated (CNDT) Q4 2025 Earnings Call Transcript Conduent Incorporated 2025 Q4 - Results - Earnings Call Presentation Conduent Q1 2026 Earnings Preview Conduent outlines accelerated turnaround and $3.2B ACV pipeline while advancing portfolio rationalization Seeking Alpha’s Quant Rating on Conduent

iHeartMedia press release ( IHRT ): Q1 Revenue of $884M beats by $12.5M . GAAP Operating income of $1.5 million, compared to a GAAP Operating loss of $25 million in Q1 2025, improvement of 105.8% Consolidated Adjusted EBITDA of $93 million, compared to $105 million in Q1 2025, down 11.4% Cash used for operating activities of $93 million Free Cash Flow of $(114) million Cash balance and total available liquidity2 of $135 million and $495 million, respectively, as of March 31, 2026 Q1 2026 Digital Audio Group Results Digital Audio Group Revenue of $327 million up 18% Podcast Revenue of $147 million up 27% Digital Revenue excluding Podcast of $180 million up 12% Segment Adjusted EBITDA of $87 million flat Digital Audio Group Adjusted EBITDA margin of 26.5% Q1 2026 Multiplatform Group Results Multiplatform Group Revenue of $493 million up 4% Excluding Multiplatform Group Q1 Political Revenue, Multiplatform Group Q1 Revenue up 4% Segment Adjusted EBITDA of $47 million down 33% Multiplatform Group Adjusted EBITDA margin of 9.5% Q2 2026 Guidance Consolidated Revenue expected to increase low-single digits Consolidated Adjusted EBITDA3 expected to be approximately $140 million to $160 million Full Year 2026 Guidance Consolidated Adjusted EBITDA3 expected to be approximately $800 million Free Cash Flow of approximately $200 million Announced that will pay minimal cash taxes in 2026 Announced a new cost savings program of $50 million of annualized cost savings, beginning in second half 2026; in addition to $100 million of in-year 2026 savings previously announced Total Programmatic Revenue of approximately $200 million, up approximately 50% Year End 2026 Net Debt to Adjusted EBITDA ("net leverage")4 to be in mid-fives Click to enlarge More on iHeartMedia Sirius XM: iHeartMedia Deal Could Put The Cash Flow Thesis At Risk Analyzing The Potential Sirius XM And iHeartMedia Merger Sirius XM: iHeartMedia Deal Could Be Financially Compelling iHeartMedia gains on report of merger talk...

Enanta Pharma press release ( ENTA ): Q1 GAAP EPS of -$0.45 beats by $0.04 . Revenue of $17.16M (+14.9% Y/Y) beats by $0.07M . More on Enanta Pharma Seeking Alpha’s Quant Rating on Enanta Pharma Historical earnings data for Enanta Pharma Financial information for Enanta Pharma

Galeanu Mihai/iStock via Getty Images Transcript U.S. equities are hitting new highs even as the Strait of Hormuz remains effectively closed, deepening supply chain disruptions. We think markets are pricing in both an AI-driven earnings boost and the impact of those disruptions - not signaling a disconnect. 1) No market disconnect With U.S. stock indexes pushing to new highs, a common narrative is that markets are disconnected. Equities and credit are both holding firm even as oil, commodities and yields rise. We disagree. Outside the U.S., we are seeing sharp dispersion across regional and sector stock performance that fit this picture. In the U.S., earnings expectations have surged, with expected S&P 500 earnings growth in the first quarter doubling to 28% since the start of April. Even regions that are vulnerable to the energy disruptions are powering ahead due to the AI theme, such as parts of Asia. 2) Yields reflect the shock Supply chain disruptions have pushed up energy costs, adding to already sticky inflation that’s pushed up government bond yields as a result. Higher yields come as we see heightened demand for capital, adding to upward pressure on interest rates. Lots of that is tied to the capital-intensive AI buildout and the rebuilding of key infrastructure. 3) Fragilities exposed by supply disruptions Our pro-risk stance is unchanged, and we stay overweight U.S. and emerging market equities. We’re underweight long-term U.S. government bonds, favoring short- and medium-term Treasuries for income. But a prolonged closure to the Strait of Hormuz that keeps energy flows disrupted would likely shift the balance. It would lift inflation and interest rates enough to start weighing on equity valuations and tightening financial conditions. We see no disconnect between record U.S. equity prices and elevated oil, commodities and bond yields. Markets are pricing both AI-driven growth and the impact of the Middle East supply shock. We stay pro-risk for now. _______...

SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the first quarter ended March 31, 2026.

SHAKOPEE, Minn., May 11, 2026 (GLOBE NEWSWIRE) -- Canterbury Park Holding Corporation (“Canterbury” or the “Company”) (Nasdaq: CPHC), today reported financial results for the first quarter ended March 31, 2026.

– LOQTORZI ® net revenue of $11.8 million in Q1 2026 –

PHILADELPHIA, May 11, 2026 (GLOBE NEWSWIRE) -- Enviri Corporation (NYSE: NVRI) (the "Company") today reported first quarter 2026 results. Revenues in the first quarter of 2026 totaled $550 million, and on a U.S. GAAP ("GAAP") basis, the consolidated loss from continuing operations was $8 million. Adjusted EBITDA was $65 million in the first quarter of 2026.

First participant dosed in FORTIFY, a Phase 1b indication expansion trial of PLN-101095 Oral presentation at AACR 2026 featured updated data from Phase 1 trial of PLN-101095 showing deepening of confirmed responses in checkpoint inhibitor-refractory solid tumors

SAN FRANCISCO, May 11, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB) today reported financial results for the first quarter 2026 and provided an update on the company’s recent developments.

First Quarter 2026 and Selected Highlights:

Quarter-over-quarter Revenue Growth Across All Product Lines, Margin Expansion and Reduced Operating Expenses Quarter-over-quarter Revenue Growth Across All Product Lines, Margin Expansion and Reduced Operating Expenses

Kaltura released an updated investors presentation that showcases its interactive agentic-AI avatar technology Kaltura released an updated investors presentation that showcases its interactive agentic-AI avatar technology

Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451

CHANDLER, Ariz., May 11, 2026 (GLOBE NEWSWIRE) -- VirTra, Inc . (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use-of-force and firearms training simulators, reported results for the first quarter ended March 31, 2026. The financial statements are available on VirTra’s website and here .

Amplify Energy Announces First Quarter 2026 Results and Announces Beta Field Royalty Relief

Key PointsIntuitive Surgical's growing installed base strengthens its competitive edge.

Saying that shares of automaker Nio (NYSE: NIO) have been volatile would be an understatement. Since going public in 2018, shares rose as much as 850% as recently as 2021, only to give back all of those gains. As of this writing, shares are down 11% since Nio's IPO. Is it possible that Nio could surge tenfold from here? Let's see how it could happen and whether the company can get there. Continue reading

In trading on Monday, shares of the First Trust Financials AlphaDEX Fund ETF (Symbol: FXO) crossed below their 200 day moving average of $58.92, changing hands as low as $58.63 per share. First Trust Financials AlphaDEX Fund shares are currently trading off about 0.9% on the da

At Holdings Channel, we have reviewed the latest batch of the 78 most recent 13F filings for the 03/31/2026 reporting period, and noticed that iShares Trust - Core S&P 500 Exchange Traded Fund (Symbol: IVV) was held by 38 of these funds. When hedge fund managers appear to be

Halozyme Therapeutics press release ( HALO ): Q1 Non-GAAP EPS of $1.60 beats by $0.08 . Revenue of $376.71M (+42.2% Y/Y) beats by $17.66M . The Company is reiterating its 2026 financial guidance ranges, which were last provided on February 17, 2026. For the full year 2026, the Company expects: Total revenue of $1.710 billion to $1.810 billion vs consensus of $1.76B, representing growth of 22% to 30% over 2025 total revenue, primarily driven by increases in royalty revenue and product sales from API. Revenue from royalties of $1.130 billion to $1.170 billion, representing growth of 30% to 35% over 2025. Adjusted EBITDA of $1.125 billion to $1.205 billion, representing growth of 71% to 83% over 2025, including new Hypercon™ and Surf Bio investment of approximately $60 million. Non-GAAP diluted earnings per share of $7.75 to $8.25 vs consensus of $8.09, representing growth of 87% to 99% over 2025. The Company's earnings per share guidance includes new Hypercon™ and Surf Bio investment of approximately $60 million and does not consider the impact of potential future share repurchases. More on Halozyme Therapeutics Halozyme Therapeutics: The Royalty Engine Is Becoming A Drug-Delivery Toll Road Halozyme Therapeutics, Inc. (HALO) Presents at The Citizens Life Sciences Conference 2026 Transcript Halozyme Therapeutics, Inc. (HALO) Presents at Leerink Global Healthcare Conference 2026 Transcript Argenx wins FDA nod to broaden Vyvgart label in myasthenia gravis Halozyme Therapeutics Q1 2026 Earnings Preview

In trading on Monday, shares of the VanEck Vectors Solar Energy ETF (Symbol: KWT) crossed below their 200 day moving average of $38.45, changing hands as low as $38.21 per share. VanEck Vectors Solar Energy shares are currently trading down about 1.3% on the day. The chart bel

Source: Bloomberg, 14:11

In trading on Monday, shares of the ProShares Online Retail ETF (Symbol: ONLN) crossed below their 200 day moving average of $58.14, changing hands as low as $57.38 per share. ProShares Online Retail shares are currently trading off about 2.2% on the day. The chart below shows

In trading on Monday, shares of Loews Corp. (Symbol: L) crossed below their 200 day moving average of $103.39, changing hands as low as $102.94 per share. Loews Corp. shares are currently trading down about 1.5% on the day. The chart below shows the one year performance of L s

AMD reportedly preparing new AM5 boards or chipsets for summer HWCooling.net